BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
42 results:

  • 1. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
    Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
    Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial.
    Barbosa-Cortés L; Martínez-Vieyra X; Mejía-Aranguré JM; López-Alarcón M; Martin-Trejo J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Atilano-Miguel S; Rodríguez-Cruz M; Maldonado-Hernández J; Añoveros-Barrera A; Solís-Labastida KA; Espinoza-Hernández L; Nuñez-Villegas NN; Jiménez-Hernández E; Bautista-Martínez BA; Juárez-Moya A; Hernández-Piñón Z; Pérez-Casillas RX
    Clin Nutr; 2023 Sep; 42(9):1759-1769. PubMed ID: 37549598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial.
    Barbosa-Cortes L; Atilano-Miguel S; Martin-Trejo JA; Jiménez-Aguayo E; Martínez-Becerril FI; López-Alarcón M; Mejía Aranguré JM; Maldonado-Hernández J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Añoveros-Barrera A; Solis-Labastida KA; Bautista-Martinez BA; Juárez-Moya A; Hernández-Piñón Z; Espinoza Hernández LE; Núñez-Villegas NN; Jiménez-Hernández E; Pérez-Casillas RX
    Front Endocrinol (Lausanne); 2023; 14():1120364. PubMed ID: 37124732
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detection and clinical significance of serum epo levels in patients with haematological tumours.
    Zhao Y; Zhang W; Cong D; Bai Y
    Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):33-36. PubMed ID: 37114311
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis.
    Barrios-Ruiz A; Davila-Gonzalez D; Fountain E; Cheng L; Verstovsek S; Rojas-Hernandez CM
    Sci Rep; 2022 Mar; 12(1):4674. PubMed ID: 35304527
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (timp-1) in the clinical progression of pediatric acute lymphoblastic leukemia.
    Saleh M; Khalil M; Abdellateif MS; Ebeid E; Madney Y; Kandeel EZ
    Hematology; 2021 Dec; 26(1):758-768. PubMed ID: 34555302
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute leukemia.
    Al-Shaibani E; Cyriac S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e559-e568. PubMed ID: 33678592
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A monocentric study on the management of patients with myelodysplastic syndromes in Morocco].
    Maaroufi HE; Ababou M; Hammani A; Ahchouch S; Jennane S; Mahtat M; Mikdmae M; Messaoudi N; Doghmi K
    Pan Afr Med J; 2020; 37():300. PubMed ID: 33654519
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chemotherapeutics for Acute Erythroid leukemia: Research, Present and Future.
    Liao Z; Li J; Wu J; Liu J; Sun S
    Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
    Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid leukemia Treated with Imatinib.
    Cesini L; Carmosino I; Breccia M; De Benedittis D; Mohamed S; De Luca ML; Colafigli G; Molica M; Scalzulli E; Massaro F; Mariggiò E; Rizzo L; Loglisci MG; Scamuffa MC; Vozella F; Diverio D; Mancini M; Alimena G; Foà R; Latagliata R
    Oncol Res Treat; 2019; 42(12):660-664. PubMed ID: 31593970
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictors of residential mobility and its impact on air pollution exposure among children diagnosed with early childhood leukemia.
    Tee Lewis PG; Chen TY; Chan W; Symanski E
    J Expo Sci Environ Epidemiol; 2019 Jun; 29(4):510-519. PubMed ID: 30770842
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The tissue inhibitor of metalloproteinases-1 (timp-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Development of acute lymphoblastic leukemia with IgH-epoR in a patient with secondary erythrocytosis.
    Sakamoto K; Tanaka S; Tomoyasu C; Tomii T; Yano M; Takagi K; Yasuhiko T; Uoshima N; Komatsu H; Imamura T
    Int J Hematol; 2016 Dec; 104(6):741-743. PubMed ID: 27544511
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
    Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
    Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
    Buccisano F; Piccioni AL; Nobile C; Criscuolo M; Niscola P; Tatarelli C; Fianchi L; Villivà N; Neri B; Carmosino I; Gumenyuk S; Mancini S; Voso MT; Maurillo L; Breccia M; Zini G; Venditti A; Fenu S; Spiriti MA; Latagliata R;
    Ann Hematol; 2016 Jun; 95(7):1059-65. PubMed ID: 27091349
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
    Zeidan AM; Sekeres MA; Wang XF; Al Ali N; Garcia-Manero G; Steensma DP; Roboz G; Barnard J; Padron E; DeZern A; Maciejewski JP; List AF; Komrokji RS;
    Am J Hematol; 2015 Nov; 90(11):1036-40. PubMed ID: 26284571
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients.
    Kováč M; Vášková M; Petráčková D; Pelková V; Mejstříková E; Kalina T; Žaliová M; Weiser J; Starý J; Hrušák O
    Eur Cytokine Netw; 2014 Mar; 25(1):8-13. PubMed ID: 24998352
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.